Takeda's Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years | Business

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 3, 2023--

Related Keywords

Sri Lanka ,Indonesia ,Colombia ,Dominican Republic ,Nicaragua ,Osaka ,Japan ,Massachusetts ,United States ,Panama ,Philippines ,Argentina ,Thailand ,Brazil ,Japanese ,America ,Maiko Miura ,Charlotte Mccormack ,Gary Dubin ,Takeda Pharmaceutical Company ,International Media ,Strategic Advisory Group Of Experts ,Takeda Pharmaceutical Company Limited ,Data Monitoring Committee ,World Health Organization ,European Union Eu Member States ,Exchange Commission ,Strategic Advisory Group ,Dengue Tetravalent Vaccine ,Latin America ,Global Vaccine Business Unit ,Dengue Efficacy Study ,European Union ,Member States ,Product Characteristics ,Annual Report ,Published March ,Tetravalent Dengue Vaccine Candidate ,Northern European Conference ,Travel Medicine ,Retrieved October ,Tetravalent Dengue Vaccine ,Healthy Children ,Retrieved July ,Health Organization ,Technical Report Series ,What You Need ,Published April ,Business Wire ,Business ,